10x Genomics (TXG) vs Veeva Systems Inc. (VEEV)
10x Genomics and Veeva Systems Inc. are both Health Information Services companies. Veeva Systems Inc. is the larger, with a market value of $44.5B against $11.1B — 4.0× the size. 10x Genomics has negative trailing earnings, so its P/E is not meaningful; Veeva Systems Inc. trades at 45.2×. Veeva Systems Inc. grew revenue faster over the last twelve months: 16.5% against −4.28%. Veeva Systems Inc. has the higher net margin (29.3% vs −12.2%) and the higher return on invested capital (343.1% vs −20.2%). Across the 19 metrics below, Veeva Systems Inc. leads on 17 and 10x Genomics on 2.
Valuation
Profitability
| Metric | TXG | VEEV | Health Information Services median |
|---|---|---|---|
| Gross margin | 70.03% | 74.96% | 63.38% |
| Operating margin | (14.33%) | 29.93% | (8.35%) |
| Net margin | (12.18%) | 29.34% | (14.70%) |
| Free cash flow margin | 19.68% | 47.39% | 0.58% |
| Return on equity | (9.40%) | 14.42% | (6.82%) |
| Return on assets | (7.47%) | 11.90% | (6.02%) |
| Return on invested capital | (20.20%) | 343.12% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack